Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease. - Wikidata - awgldk - TriplyDB

Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.

Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.

http://www.wikidata.org/entity/Q37981953

about

Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders Potent effects of dioscin against liver fibrosis.Shaofu Zhuyu decoction ameliorates obesity-mediated hepatic steatosis and systemic inflammation by regulating metabolic pathways Jiao tai wan attenuates hepatic lipid accumulation in type 2 diabetes mellitus Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat.Recent advances in the herbal treatment of non-alcoholic Fatty liver disease.Psoralea corylifolia L. Seed Extract Attenuates Nonalcoholic Fatty Liver Disease in High-Fat Diet-Induced Obese Mice.Total saponins from Rosa laevigata Michx fruit attenuates hepatic steatosis induced by high-fat diet in rats.Untargeted Metabolomics Reveals Intervention Effects of Total Turmeric Extract in a Rat Model of Nonalcoholic Fatty Liver Disease Protective Effects of Dioscin against Lipopolysaccharide-Induced Acute Lung Injury through Inhibition of Oxidative Stress and Inflammation Icaritin ameliorates carbon tetrachloride-induced acute liver injury mainly because of the antioxidative function through estrogen-like effects.Effect of berberine on the ratio of high-molecular weight adiponectin to total adiponectin and adiponectin receptors expressions in high-fat diet fed rats.Genipin alleviates high-fat diet-induced hyperlipidemia and hepatic lipid accumulation in mice via miR-142a-5p/SREBP-1c axis.Protective effects of calycosin against CCl4-induced liver injury with activation of FXR and STAT3 in mice Potential protective effect ofNigella sativacrude oils towards fatty liver in rats Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway

P2860

Q26747523-74B87E7C-FB27-4954-B2B0-0EAA62944072 Q35317884-062654D6-0694-454F-B519-BF599526A7FD Q36389547-94397C00-8D1F-4F09-8C75-A285E2A8EF49 Q37351506-8CF4D179-3202-4F74-9477-83F00A2AD41C Q37501044-6C74CBD0-054E-4E4C-982D-C97241050962 Q37585296-2B060267-5F83-42B1-BD4D-A2AD0E92C95C Q38687860-46282F06-90F8-4180-AFFE-6BE21462C292 Q39114185-AC951B53-F38C-42B4-8C28-3AAB8FAFB7E3 Q42048460-FF9EE1FF-18A1-4790-B50F-E35C74E94F86 Q42315097-E4A9BBBE-336D-4FEC-9FD7-AEF0D734D8C0 Q46848866-7FDD6CF6-1BDA-4384-828B-A2CEE2949357 Q47254809-FC0BAD31-2848-47C6-A656-4D1D9F4062EC Q47380801-0756200F-4B3C-49A1-8963-D0948ADBA233 Q57147154-CE552D45-2613-4BF1-9134-3A240301A7DC Q57633199-52D561E2-B6E6-475B-92F2-1DD3BDD70BBE Q58603577-C512F289-A17A-4916-AFCB-C67952630DD3

P2860

Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.

http://www.wikidata.org/entity/Q37981953

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.

@en

Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.

@nl

type

label

Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.

@en

Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.

@nl

prefLabel

Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.

@en

Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.

@nl

P1433

Q37981953-7FCB4029-E973-48F6-939A-EF97F4FAE8D7

P1476

Q37981953-6648A807-29CC-4296-9135-F45206CCA72F

P2093

Q37981953-3409DC3B-AED2-4DD3-BBA6-3BA99F60588C

Q37981953-678EBCBD-9AF4-40FD-A0BC-37CE521094FE

Q37981953-903D78A4-8F9A-4FF6-8D40-B2685092D121

P2860

Q37981953-061278A9-F99F-462B-A699-E9291DDF6847

Q37981953-0C5A2B87-55A2-41F1-9A27-3B2FEAF391EA

Q37981953-194C4428-F806-4681-A4DE-9AA2D7DDB006

Q37981953-21975056-7BB0-4F77-B4DD-CC7E9D20F0D6

Q37981953-2249D5E5-BBF7-473F-AD29-360C944AFA10

Q37981953-25E324E8-E1DB-492E-9DA8-DE4DFE4AF984

Q37981953-2B1F705B-545F-4D43-8C28-D1F5E72FBAEB

Q37981953-2D121120-EEEC-4150-87BC-51F4E31A0C9A

Q37981953-2EE4F114-2F0B-4544-9FC4-CE582C7C54A1

Q37981953-3173F855-75F8-4B0A-BD18-B415D3F6DC7C

P2888

Q37981953-8AC3F03A-DC99-4F27-9B42-3C1C6FA68F8D

P304

Q37981953-2CD6E2D6-C04B-428B-ACDF-E51A738108AB

P31

Q37981953-06768D93-6E55-4615-999D-8251CA739EF1

P356

Q37981953-CE25AF52-12F0-415E-B3AF-516398325BB3

P433

Q37981953-F7ABA9E9-687B-4A4A-A98B-F7DF6D7E3729

P478

Q37981953-602E5AE4-95EE-43D7-A8B9-534D9ABDB8CF

P577

Q37981953-9B5B0B06-4397-4570-8E20-6D266914EF08

P698

Q37981953-0EAB1686-69C8-4DDF-80CD-1A17F433C181

P356

S11655-012-0993-2

P1433

Chinese Journal of Integrated Medicine

P1476

Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.

@en

P2093

Fu-Er Lu

http://www.w3.org/2001/XMLSchema#string

Hui Dong

http://www.w3.org/2001/XMLSchema#string

Li Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Berberine improves glucose metabolism through induction of glycolysis

Acetaldehyde-induced interleukin-1beta and tumor necrosis factor-alpha production is inhibited by berberine through nuclear factor-kappaB signaling pathway in HepG2 cells

Regulation effects on abnormal glucose and lipid metabolism of TZQ-F, a new kind of Traditional Chinese Medicine

The metabolic benefits of Polygonum hypoleucum Ohwi in HepG2 cells and Wistar rats under lipogenic stress

Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury

Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats

AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy

Nonalcoholic fatty liver disease

Epidemiology of non-alcoholic fatty liver disease in China.

[Effects of cembrane-type diterpenes on proliferation of PC12 cells and their antagonistic effects on neurotoxicity induced by glutamate].

P2888

s11655-012-0993-2

P304

152-160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11655-012-0993-2

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22311412

http://www.w3.org/2001/XMLSchema#string